The FDA has requested the labeling for all desmopressin products be updated to include new information about severe hyponatremia and seizures. Certain patients, including children treated with ...
MedPage Today on MSN
FDA Approves Desmoda for Central Diabetes Insipidus
Liquid alternative to desmopressin tablets allows for more precise dosing ...
FDA authorized desmopressin acetate oral solution (Desmoda) for CDI/AVP-D across all ages, representing the first FDA-approved oral liquid desmopressin formulation in the United States.
Intranasal desmopressin (DDAVP, DDVP, Minirin, Stimate Nasal Spray) is no longer indicated for primary nocturnal enuresis and is associated with an increased risk of severe hyponatremia (possibly ...
Desmopressin acetate 10mcg/spray; nasal spray; contains benzalkonium chloride. Desmopressin acetate is a synthetic analogue of the natural hormone arginine vasopressin. Upon binding of desmopressin to ...
PARSIPPANY, N.J., Oct. 22, 2014 /PRNewswire-USNewswire/ – Ferring Pharmaceuticals is pleased to announce that the company has acquired DDAVP® (desmopressin acetate) from Sanofi. Ferring is the ...
DESMODA is the first and only FDA-approved desmopressin oral solutionCommercial launch expected on March 9thDESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing ...
ROCKVILLE, Md., Dec.4, 2007-- FDA notified healthcare professionals and patients of the Agency's request that manufacturers update the prescribing information for desmopressin to include important new ...
Isreali drugmaker Teva Pharmaceutical Industries has received the regulatory nod in the USA for its Abbreviated New Drug Application for Desmopressin Acetate Tablets, 0.1mg and 0.2mg. Isreali ...
December 5, 2007 — Desmopressin acetate intranasal formulations are no longer indicated for the treatment of primary nocturnal enuresis (PNE) because of the risk for severe hyponatremia that can lead ...
Feb. 18, 2005 — The U.S. Food and Drug Administration (FDA) has approved a first-time generic formulation of terconazole vaginal cream 0.4% for the treatment of vulvovaginal candidiasis; a first-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results